Intriguingly, anti-PD-1 treatment strongly prolonged the survival time and increased the tumor infiltration of Cd8+ T cells in the Stoml2-overexpressing group, while immunotherapy had a limited effect on the mice survival and moderately increased the proportion of infiltration Cd8+ T cells (Fig. 3e, f). Here, STOML2 is linked to neoplasm.